Rocha A M O, Len C A, Santos F H, Iglesias S B O, Bissoto J R
Department of Pediatrics - Paulista School of Medicine - Federal University of Sao Paulo- UNIFESP, Brazil.
Department of Pediatrics - Paulista School of Medicine - Federal University of Sao Paulo- UNIFESP, Brazil.
J Ayurveda Integr Med. 2024 Sep-Oct;15(5):101035. doi: 10.1016/j.jaim.2024.101035. Epub 2024 Oct 1.
Integrative practices have been incorporated into palliative care to provide holistic and multidimensional care for patients. This study aims to identify the scope of integrative practices, specifically whole medical systems, and demonstrate its safety and efficacy, specially in children with cerebral palsy. Key databases, including Embase, Cochrane, Medline/PubMed, Scopus, Google Scholar, Lilacs and Scielo were searched using specific terms. Only randomized and non-randomized clinical trials were included for meta-analysis purposes. Case-control, cohort, cross-sectional or retrospective observational studies were also included for the systematic review. Participants included children aged 0-18 years receiving palliative care for cerebral palsy and undergoing Ayurvedic Medicine practices. Descriptive analysis was conducted, including data such as year; author; design; sample size; intervention and comparison; outcomes and conclusion. Two interventional studies compared Ayurvedic practices with each other or with physiotherapy in children with cerebral palsy. The meta-analysis demonstrated an improvement in spasticity for children using Ayurvedic medicine. However, there were limitations in terms of heterogeneity in interventions, control groups, and assessed outcomes. Integrative practices, including Ayurvedic medicine have the potential to improve quality of life, manage disease symptoms and provide emotional support. However, more robust evidence is needed to support their widespread use. The use of Ayurvedic medicine showed evidence of improvement in spasticity for children with cerebral palsy. REGISTRATION NUMBER: Prospero CRD 42020198399.
综合疗法已被纳入姑息治疗，为患者提供全面和多维度的护理。本研究旨在确定综合疗法，特别是整个医学体系的范围，并证明其安全性和有效性，特别是对脑瘫儿童。使用特定术语检索了包括Embase、Cochrane、Medline/PubMed、Scopus、谷歌学术、Lilacs和Scielo在内的主要数据库。仅纳入随机和非随机临床试验进行荟萃分析。病例对照、队列、横断面或回顾性观察性研究也纳入系统评价。参与者包括0至18岁接受脑瘫姑息治疗并接受阿育吠陀医学疗法的儿童。进行了描述性分析，包括年份、作者、设计、样本量、干预和对照、结果和结论等数据。两项干预性研究比较了阿育吠陀疗法相互之间或与脑瘫儿童物理治疗的效果。荟萃分析表明，使用阿育吠陀医学的儿童痉挛症状有所改善。然而，在干预措施、对照组和评估结果的异质性方面存在局限性。包括阿育吠陀医学在内的综合疗法有潜力改善生活质量、控制疾病症状并提供情感支持。然而，需要更有力的证据来支持其广泛应用。使用阿育吠陀医学显示出对脑瘫儿童痉挛症状有改善的证据。注册号：Prospero CRD 42020198399。
